-
Je něco špatně v tomto záznamu ?
Self-stigma and treatment effectiveness in patients with anxiety disorders - a mediation analysis
M. Ociskova, J. Prasko, K. Vrbova, P. Kasalova, M. Holubova, A. Grambal, K. Machu,
Jazyk angličtina Země Nový Zéland
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2009
Free Medical Journals
od 2005
PubMed Central
od 2005
Europe PubMed Central
od 2005
ProQuest Central
od 2005-01-01
Open Access Digital Library
od 2005-01-01
Open Access Digital Library
od 2009-01-01
Taylor & Francis Open Access
od 2010-12-01
Nursing & Allied Health Database (ProQuest)
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
Psychology Database (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2005
PubMed
29416340
DOI
10.2147/ndt.s152208
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
Goal: The goal of this study was to explore the impact of self-stigma on the treatment outcomes in patients with anxiety disorders and to find possible mediators of this relationship. Method: Two hundred and nine patients with anxiety disorders, who were hospitalized in a psychotherapeutic department, attended the study. The average age was 39.2±12.4 years; two-thirds were women. Most of the patients used a long-term medication. The participants underwent either cognitive behavioral therapy (CBT) or short psychodynamic therapy. The selection to the psychotherapy was not randomized. All individuals completed several scales - Beck Depression Inventory, the second edition (BDI-II), Beck Anxiety Inventory (BAI), Dissociative Experience Scale (DES), Sheehan Disability Scale (SDS), subjective Clinical Global Impression (subjCGI), and The Internalized Stigma of Mental Illness Scale (ISMI). A senior psychiatrist filled out the objective CGI (objCGI). Results: The patients significantly improved in the severity of anxiety (BAI), depression (BDI-II), and overall severity of the mental disorder (objCGI). The self-stigma predicted a lower change of the objCGI, but not a change of the anxiety and depressive symptoms severity. Anxiety, depressive symptoms, dissociation, and disability were assessed as possible mediators of the relationship between the self-stigma and the treatment change. None of them were significant. Conclusion: Self-stigma lowers the effectiveness of the combined treatment of anxiety disorders. Future research should explore other possible mediators influencing this relationship.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18010021
- 003
- CZ-PrNML
- 005
- 20180404131319.0
- 007
- ta
- 008
- 180404s2018 nz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.2147/NDT.S152208 $2 doi
- 035 __
- $a (PubMed)29416340
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a nz
- 100 1_
- $a Ociskova, Marie $u Department of Psychiatry, Faculty of Medicine and Dentistry, Palacky University, University Hospital, Olomouc.
- 245 10
- $a Self-stigma and treatment effectiveness in patients with anxiety disorders - a mediation analysis / $c M. Ociskova, J. Prasko, K. Vrbova, P. Kasalova, M. Holubova, A. Grambal, K. Machu,
- 520 9_
- $a Goal: The goal of this study was to explore the impact of self-stigma on the treatment outcomes in patients with anxiety disorders and to find possible mediators of this relationship. Method: Two hundred and nine patients with anxiety disorders, who were hospitalized in a psychotherapeutic department, attended the study. The average age was 39.2±12.4 years; two-thirds were women. Most of the patients used a long-term medication. The participants underwent either cognitive behavioral therapy (CBT) or short psychodynamic therapy. The selection to the psychotherapy was not randomized. All individuals completed several scales - Beck Depression Inventory, the second edition (BDI-II), Beck Anxiety Inventory (BAI), Dissociative Experience Scale (DES), Sheehan Disability Scale (SDS), subjective Clinical Global Impression (subjCGI), and The Internalized Stigma of Mental Illness Scale (ISMI). A senior psychiatrist filled out the objective CGI (objCGI). Results: The patients significantly improved in the severity of anxiety (BAI), depression (BDI-II), and overall severity of the mental disorder (objCGI). The self-stigma predicted a lower change of the objCGI, but not a change of the anxiety and depressive symptoms severity. Anxiety, depressive symptoms, dissociation, and disability were assessed as possible mediators of the relationship between the self-stigma and the treatment change. None of them were significant. Conclusion: Self-stigma lowers the effectiveness of the combined treatment of anxiety disorders. Future research should explore other possible mediators influencing this relationship.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Prasko, Jan $u Department of Psychiatry, Faculty of Medicine and Dentistry, Palacky University, University Hospital, Olomouc.
- 700 1_
- $a Vrbova, Kristyna $u Department of Psychiatry, Faculty of Medicine and Dentistry, Palacky University, University Hospital, Olomouc.
- 700 1_
- $a Kasalova, Petra $u Department of Psychiatry, Faculty of Medicine and Dentistry, Palacky University, University Hospital, Olomouc.
- 700 1_
- $a Holubova, Michaela $u Department of Psychiatry, Faculty of Medicine and Dentistry, Palacky University, University Hospital, Olomouc.
- 700 1_
- $a Grambal, Ales $u Department of Psychiatry, Faculty of Medicine and Dentistry, Palacky University, University Hospital, Olomouc.
- 700 1_
- $a Machu, Klara $u Department of Psychology, Faculty of Arts, University of Ostrava, Ostrava, The Czech Republic.
- 773 0_
- $w MED00183034 $t Neuropsychiatric disease and treatment $x 1176-6328 $g Roč. 14, č. - (2018), s. 383-392
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29416340 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180404 $b ABA008
- 991 __
- $a 20180404131358 $b ABA008
- 999 __
- $a ind $b bmc $g 1287506 $s 1006833
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 14 $c - $d 383-392 $e 20180126 $i 1176-6328 $m Neuropsychiatric disease and treatment $n Neuropsychiatr Dis Treat $x MED00183034
- LZP __
- $a Pubmed-20180404